MUMBAI, India, Jan. 31 -- Intellectual Property India has published a patent application (202427102208 A) filed by Serum Institute Of India Pvt. Ltd., Pune, Maharashtra, on Dec. 23, 2024, for 'multivalent covid-19 vaccines based on adenoviral vectors.'
Inventor(s) include Shaligram, Umesh Sharadrao; and Narwade, Santosh Chandrakant.
The application for the patent was published on Jan. 31, under issue no. 05/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to the construction of Adenovirus-based vectors und to their use for inducing a broad, robust and durable cellular and humoral immune response in a subject."
The patent application was internationally filed on May 25, 2023, und...